Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance

Quest Diagnostics IncTrade
iShares Broad USD Investment Grade Corporate BondTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.

DGXUSIG
Market Cap
$26.21B
Sector
HealthFixed Income
52-Week High
$238.50$52.69
52-Week Low
$173.49$50.18
Enterprise Value
$31.97B
Dividend Yield
1.45%

Returns comparison

Trailing returns across standard periods

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX

About iShares Broad USD Investment Grade Corporate Bond

USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.

Read more on USIG